# Chromium Gluconate

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/chromium-gluconate
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-25
**Evidence Score:** 2 / 10
**Category:** Mineral
**Also Known As:** Chromium(III) gluconate, Cr gluconate, Trivalent chromium gluconate, Chromic gluconate, Chromium trigluconate, GTF chromium precursor

## Overview

Chromium gluconate is a chelated form of trivalent chromium (Cr³⁺) bound to gluconic acid, designed to enhance bioavailability and gastrointestinal tolerability compared to inorganic chromium salts. Its primary mechanism involves potentiating insulin receptor tyrosine kinase activity, which amplifies downstream glucose uptake signaling in muscle and adipose tissue.

## Health Benefits

• Supports glucose metabolism by increasing insulin binding to cells and insulin receptor activity (mechanism identified, no clinical trials available)
• Enhances insulin receptor signaling through tyrosine kinase, PI3K, and Akt pathways (biochemical evidence only)
• May improve glucose uptake via Glut4 translocation (theoretical based on mechanism, no human studies)
• Forms glucose tolerance factor (GTF) complexes that support insulin function (mechanistic data only)
• Potentially assists in blood sugar regulation through enhanced [insulin sensitivity](/ingredients/condition/weight-management) (inferred from mechanism, lacks clinical validation)

## Mechanism of Action

Chromium gluconate delivers trivalent chromium (Cr³⁺) that binds to the low-molecular-weight chromium-binding substance (LMWCr), also called chromodulin, which then activates insulin receptor tyrosine kinase to amplify intracellular insulin signaling. This potentiation cascades through phosphatidylinositol 3-kinase (PI3K) and protein kinase B (Akt), promoting GLUT4 transporter translocation to the cell membrane for enhanced glucose uptake. The gluconate carrier ligand improves intestinal absorption relative to chromium chloride, though absolute bioavailability across all chelated forms remains under investigation.

## Clinical Summary

Direct clinical trials isolating chromium gluconate as a standalone intervention are currently unavailable, limiting specific efficacy conclusions for this particular salt form. Broader chromium supplementation research — predominantly using chromium picolinate at doses of 200–1000 mcg/day — shows modest improvements in fasting glucose (reductions of 5–15 mg/dL) and HbA1c in individuals with type 2 diabetes or [insulin resistance](/ingredients/condition/weight-management) across multiple small randomized controlled trials. A 2014 meta-analysis of 25 RCTs found chromium supplementation significantly reduced fasting blood glucose (mean difference: −0.84 mmol/L) and HbA1c, though trial heterogeneity and small sample sizes (typically 30–100 participants) limit generalizability. Evidence for chromium gluconate specifically relies on biochemical plausibility and absorption pharmacokinetics rather than direct human clinical outcomes data.

## Nutritional Profile

Chromium Gluconate is an organic mineral supplement providing trivalent chromium (Cr³⁺) complexed with gluconic acid. Each molecule consists of one chromium ion bound to three gluconate ligands, with a molecular weight of approximately 574.35 g/mol. Chromium constitutes roughly 9.05% of the total molecular weight, meaning a typical 200 mcg elemental chromium dose requires approximately 2.21 mg of chromium gluconate compound. The gluconate carrier contributes negligible caloric value (<1 kcal per dose). No macronutrients (fat, protein, carbohydrates), vitamins, or fiber are present in meaningful amounts. Bioavailability of chromium from the gluconate form is estimated at approximately 1–3% absorption in the gastrointestinal tract, which is comparable to other organic chromium salts but generally considered lower than chromium picolinate (estimated 2–5% absorption). Absorption is enhanced by co-administration with vitamin C (ascorbic acid) and niacin (vitamin B3), and is reduced by concurrent intake of phytates, zinc, iron, and antacids due to competitive mineral absorption. Chromium is transported in the blood primarily bound to transferrin and is distributed to tissues including liver, kidney, muscle, and spleen. The biologically active form participates in the low-molecular-weight chromium-binding substance (LMWCr, historically called chromodulin), a tetranuclear chromium complex that potentiates insulin receptor signaling. Typical supplemental doses range from 50–1000 mcg of elemental chromium daily, with the Adequate Intake (AI) set at 35 mcg/day for adult males and 25 mcg/day for adult females (per the Institute of Medicine). No Tolerable Upper Intake Level (UL) has been established due to insufficient toxicity data, though trivalent chromium is generally regarded as having very low toxicity. Urinary excretion is the primary elimination route, with excess chromium readily cleared by the kidneys.

## Dosage & Preparation

No clinically studied dosage ranges, forms, or standardization details are available for chromium gluconate in the current research. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Chromium gluconate is generally well-tolerated at supplemental doses (200–1000 mcg/day of elemental chromium), with the most commonly reported adverse effects being mild gastrointestinal discomfort, nausea, and headache at higher doses. Clinically significant drug interactions exist with insulin, metformin, and other hypoglycemic agents, as concurrent use may potentiate [blood glucose](/ingredients/condition/weight-management) lowering and increase hypoglycemia risk requiring dose monitoring. Antacids, proton pump inhibitors, and calcium carbonate may reduce chromium absorption, while NSAIDs such as aspirin and ibuprofen may increase chromium absorption unpredictably. Chromium supplementation is not recommended during pregnancy or lactation beyond established adequate intake levels (29–45 mcg/day), and individuals with renal or hepatic impairment should exercise caution due to reduced clearance capacity.

## Scientific Research

No specific human clinical trials, RCTs, or meta-analyses on chromium gluconate were identified in the available research. The evidence base lacks PubMed PMIDs or controlled trial data for this particular chromium form, with only general mechanistic information about chromium's role in [glucose metabolism](/ingredients/condition/weight-management) available.

## Historical & Cultural Context

No historical or traditional medicine uses are documented for chromium gluconate, as it is a modern synthetic compound. Traditional use data is not applicable to this manufactured supplement form.

## Synergistic Combinations

Alpha-lipoic acid, Cinnamon extract, Bitter melon, Gymnema sylvestre, Vanadium

## Frequently Asked Questions

### How does chromium gluconate differ from chromium picolinate?

Chromium gluconate uses gluconic acid as its chelating ligand, while chromium picolinate uses picolinic acid; both are designed to enhance Cr³⁺ absorption over inorganic salts like chromium chloride. Chromium picolinate has substantially more direct clinical trial data behind it, whereas chromium gluconate's advantages are primarily proposed based on its gluconate carrier's gastrointestinal tolerability and absorption profile. Neither form has been directly compared head-to-head in large human trials for glycemic outcomes.

### What is the recommended dosage of chromium gluconate for blood sugar support?

No specific clinical dosing protocol has been established for chromium gluconate due to the absence of dedicated trials; however, general chromium supplementation research supports 200–1000 mcg/day of elemental chromium for glycemic effects in adults with insulin resistance or type 2 diabetes. The U.S. Adequate Intake for chromium is 25–35 mcg/day for healthy adults, meaning supplemental doses used in glucose studies are substantially higher. Always calculate the elemental chromium content of a gluconate salt product rather than the total salt weight when determining dose.

### Can chromium gluconate help with weight loss?

Some chromium supplementation studies have reported modest reductions in body fat percentage and appetite, theorized to occur through improved insulin sensitivity and stabilized blood glucose reducing cravings, but effect sizes are small and inconsistent. A 2013 meta-analysis examining chromium's effect on body composition found statistically significant but clinically marginal fat mass reductions averaging approximately 1.1 kg over study periods. No trials have examined chromium gluconate specifically for weight loss, so these findings from other chromium forms cannot be directly attributed to this compound.

### Is chromium gluconate safe to take with metformin?

Combining chromium gluconate with metformin warrants medical supervision because both agents influence glucose regulation — metformin via AMPK activation and hepatic gluconeogenesis suppression, chromium via insulin receptor potentiation — and concurrent use could enhance hypoglycemic effects beyond intended targets. Clinical monitoring of fasting glucose and HbA1c is advisable if both are used simultaneously, and dose adjustments to metformin may be necessary. There are no large-scale safety studies specifically examining this combination, so physician guidance is essential before co-administration.

### How long does it take for chromium gluconate to show effects on blood sugar?

Based on chromium supplementation research broadly, measurable changes in fasting blood glucose and insulin sensitivity typically appear after 8–16 weeks of consistent daily supplementation at doses of 200–1000 mcg elemental chromium. HbA1c reductions, which reflect a 3-month glucose average, require at least 12 weeks of supplementation before meaningful assessment is possible. No time-course data exists specifically for chromium gluconate, and individual response will vary based on baseline insulin resistance, diet, and concurrent medications.

### What foods naturally contain chromium, and can diet alone provide enough chromium gluconate?

Chromium is found in whole grains, broccoli, mushrooms, and meat, but the chromium content varies widely depending on soil chromium levels and food processing. Most dietary sources contain chromium in different forms than chromium gluconate, and typical diets provide only 20–50 mcg daily, which is below the amount used in supplementation studies. Food alone may not deliver sufficient chromium for therapeutic glucose metabolism support, which is why supplementation with chromium gluconate is considered by those seeking targeted intake.

### Is chromium gluconate safe for children, and what is known about age-related differences in chromium needs?

There is limited research specifically evaluating chromium gluconate safety and dosing in children, and pediatric use should only occur under medical supervision. Children's chromium requirements are lower than adults, and excessive supplementation in young populations has not been well studied. Parents should consult healthcare providers before giving chromium gluconate to children, as evidence does not support routine pediatric supplementation.

### How strong is the clinical evidence supporting chromium gluconate's effects on glucose metabolism in humans?

Chromium gluconate's mechanism is supported by biochemical and cellular research showing effects on insulin receptor signaling pathways, but human clinical trials specifically testing chromium gluconate are limited or absent. Most evidence comes from laboratory studies and theoretical models of glucose uptake via Glut4 translocation rather than controlled human studies. The gap between biochemical evidence and human clinical data means claims about efficacy should be viewed as preliminary and not definitively proven.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*